<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T21:35:37Z</responseDate>
  <request identifier="oai:figshare.com:article/33952454" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33952454</identifier>
        <datestamp>2026-09-21T12:18:23Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_2</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Macrophage-Inspired
Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt; Nanozymes
with a Hydrophobic Spiky Topography for Treating Drug-Resistant Bacteria</dc:title>
          <dc:creator>Jia-Cheng Lv (10826746)</dc:creator>
          <dc:creator>Shi-Peng Chen (12244648)</dc:creator>
          <dc:creator>Yu-Qing Wei (25083443)</dc:creator>
          <dc:creator>Ming Yan (284631)</dc:creator>
          <dc:creator>Zhi-Guo Wang (397212)</dc:creator>
          <dc:creator>Su-Jiao Cao (25083446)</dc:creator>
          <dc:creator>Jia-Zhuang Xu (1283538)</dc:creator>
          <dc:creator>Li Qiu (242627)</dc:creator>
          <dc:creator>Zhong-Ming Li (1283526)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>ros generation sites</dc:subject>
          <dc:subject>microenvironment engineering strategy</dc:subject>
          <dc:subject>insect wing micro</dc:subject>
          <dc:subject>hydrophobic spiky topography</dc:subject>
          <dc:subject>hydrophobic nanoneedle surface</dc:subject>
          <dc:subject>hydrophobic carbon shell</dc:subject>
          <dc:subject>densely aligned nanoneedles</dc:subject>
          <dc:subject>band centers toward</dc:subject>
          <dc:subject>enhanced bacterial adhesion</dc:subject>
          <dc:subject>fold higher pod</dc:subject>
          <dc:subject>like bacterial capture</dc:subject>
          <dc:subject>resistant bacteria fe</dc:subject>
          <dc:subject>first reported nanozyme</dc:subject>
          <dc:subject>4 &lt;/ sub</dc:subject>
          <dc:subject>3 &lt;/ sub</dc:subject>
          <dc:subject>2 &lt;/ sub</dc:subject>
          <dc:subject>yielding 2</dc:subject>
          <dc:subject>bacterial membranes</dc:subject>
          <dc:subject>nanozyme achieved</dc:subject>
          <dc:subject>like activity</dc:subject>
          <dc:subject>fold lower</dc:subject>
          <dc:subject>first fda</dc:subject>
          <dc:subject>work offers</dc:subject>
          <dc:subject>treating drug</dc:subject>
          <dc:subject>pristine fe</dc:subject>
          <dc:subject>nanoparticles encapsulated</dc:subject>
          <dc:subject>hydrogen bonding</dc:subject>
          <dc:subject>holds promise</dc:subject>
          <dc:subject>fermi level</dc:subject>
          <dc:subject>engineered fe</dc:subject>
          <dc:subject>designed fe</dc:subject>
          <dc:subject>based nanomaterial</dc:subject>
          <dc:subject>architecture shifted</dc:subject>
          <dc:subject>approved transition</dc:subject>
          <dc:subject>antibacterial therapy</dc:subject>
          <dc:subject>advance fe</dc:subject>
          <dc:description>Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt;, the first reported nanozyme
and the
first FDA-approved transition-metal-based nanomaterial, holds promise
for antibacterial therapy but is limited by poor ROS catalytic activity
and utilization. Inspired by macrophage-like bacterial capture and
insect wing micro/nanostructures, we designed Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt; nanoparticles encapsulated in a conductive, hydrophobic carbon
shell with densely aligned nanoneedles. This architecture shifted
the Fe/O d/p-band centers toward the Fermi level, promoted H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; adsorption and activation, and strengthened H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; homolysis through H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;–O
hydrogen bonding, yielding 2.67-fold higher POD-like activity than
that of pristine Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt;. The hydrophobic nanoneedle
surface further inhibited continuous liquid film formation, enhanced
bacterial adhesion, and shortened the distance between ROS generation
sites and bacterial membranes, thereby improving ROS utilization.
Consequently, the engineered Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt; nanozyme
achieved an MRSA inhibitory concentration nearly 15-fold lower than
pristine Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt;. This work offers a microenvironment
engineering strategy to advance Fe&lt;sub&gt;3&lt;/sub&gt;O&lt;sub&gt;4&lt;/sub&gt;-based
antibacterial nanozymes toward clinical translation.</dc:description>
          <dc:date>2026-09-21T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Media</dc:type>
          <dc:identifier>10.1021/acs.nanolett.6c02274.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/media/Macrophage-Inspired_Fe_sub_3_sub_O_sub_4_sub_Nanozymes_with_a_Hydrophobic_Spiky_Topography_for_Treating_Drug-Resistant_Bacteria/33952454</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
